Kader, Sardar, et al. “Comparative Study Between Oral Hypoglycemic Drugs Repaglinide, Glibenclamide and Rosiglitazone on Some Biochemical Parameters in Type 2 Diabetic Patients”. Iraqi Journal of Pharmaceutical Sciences, vol. 18, no. 2, Mar. 2017, pp. 32-38, https://doi.org/10.31351/vol18iss2pp32-38.